|1.||Beer, Martin: 3 articles (08/2010 - 07/2007)|
|2.||Floegel-Niesmann, G: 3 articles (01/2003 - 11/2001)|
|3.||Yin, Hong: 2 articles (01/2014 - 11/2013)|
|4.||Wang, Guangxiang: 2 articles (01/2014 - 11/2013)|
|5.||Zhang, Delin: 2 articles (01/2014 - 11/2013)|
|6.||Wang, Yanhua: 2 articles (01/2014 - 11/2013)|
|7.||Uttenthal, Ase: 2 articles (10/2012 - 01/2010)|
|8.||Le Potier, M F: 2 articles (08/2007 - 11/2001)|
|9.||Moennig, V: 2 articles (01/2005 - 01/2003)|
|10.||Koenen, F: 2 articles (10/2004 - 11/2001)|
|1.||Classical Swine Fever (Swine Fever)
11/08/2001 - "The efficacy of two marker vaccines against classical swine fever (CSF) was tested in a large scale laboratory trial in several National Swine Fever Laboratories (NSFL) of the EU member states. "
10/01/2000 - "Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review."
05/01/2015 - "Our findings add a new strategy for the development of marker vaccines and their accompanying discrimination assays and offer an alternative to the devastating stamping out policy for Classical swine fever. "
10/05/2012 - "Marker vaccines offer the possibility to differentiate classical swine fever (CSF) infected from CSF vaccinated animals based on serology and their implementation will ensure free trade with pigs. "
08/01/2007 - "Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines."
11/08/2001 - "There was thus some protection against clinical illness by both marker vaccines, but not a solid protection against infection and virus shedding. "
12/28/2012 - "In domestic pigs strict control measures and the use of gene-deleted marker vaccines resulted in the elimination of pseudorabies virus (PrV) infections in many parts of Europe and North America. "
01/01/2010 - "However, in areas considered to be free from these diseases and in which there is the possibility of only limited outbreaks, the use of Differentiation of Infected from Vaccinated Animals (DIVA) or marker vaccines allows for vaccination while still retaining the possibility of serological surveillance for the presence of infection. "
03/01/2008 - "Recently, marker vaccines have been used in the control and eradication of bovine herpesvirus type 1 (BHV-1) infection. "
01/01/2003 - "However, for monitoring infection in a vaccinated population, marker-vaccines are preferred. "
|3.||Influenza in Birds (Avian Flu)
12/01/2005 - "Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials."
12/01/2005 - "Marker vaccines and diagnostic tests can prove to be invaluable in disease eradication and control programs, as was found in the pseudorabies (Aujeszky's Disease) virus eradication program in the U.S. "
01/01/2005 - "Attempts to eradicate endemic Aujeszky's disease from pig populations are greatly facilitated by the systematic use of deletion marker vaccines. "
09/01/1995 - "[Results of Aujeszky disease control using marker vaccines]."
06/01/1990 - "Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease."
01/01/2005 - "Currently the use of marker vaccines for emergency use to contain outbreaks of classical swine fever and foot-and-mouth disease is under discussion between stakeholders and legislators."
12/01/2005 - "Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals."
01/01/2003 - "Sub-unit marker vaccines against classical swine fever have also been developed; such vaccines are also envisaged against foot-and-mouth disease; it would permit, if satisfying defined criteria, to distinguish vaccinated from infected animals."
04/01/1994 - "Vaccination was essential in the virtual eradication of foot-and-mouth disease and classical swine fever, the use of modern marker vaccines opens prospects for eradication of viruses in countries with a high prevalence, and a rebirth of interest in bacterial vaccines is noted, because of the problems of drug resistance and antimicrobial residues. "
|4.||Recombinant DNA (Recombinant DNA Research)
|8.||Antiviral Agents (Antivirals)